Product logins

Find logins to all Clarivate products below.


Diagnostic Imaging Systems | Market Insights | Europe | 2022

The COVID-19 pandemic has had a significant impact on European diagnostic imaging market in the short term. Once the market stabilizes, however, the mature diagnostic imaging system market in Europe will see modest growth through 2030. Although ongoing digitization efforts, declining ASPs, and rising demand for diagnostic imaging procedures, fueled by a growing aging population, will support increasing adoption of new technology among European healthcare providers, overall market expansion will be hindered by budget constraints on healthcare facilities, resulting in continued delays in the replacement of imaging systems.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for diagnostic imaging systems in Europe across an 11-year

Related Medtech Insights Reports

Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Diagnostic Imaging Systems – Market Insights – China
The diagnostic imaging system market in China will see moderate growth in the overall diagnostic imaging space through 2034, driven by favorable demographic trends and the accelerating adoption of…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…